Tumour Angiogenesis and p53 Protein Expression in Mammary Phyllodes Tumors

Modern Pathology

Volumn 16, Issue 10, 2003, Pages 1007-1013

  Tse, Gary M K ^a   Lui, Philip C W ^c   Scolyer, Richard A ^e   Putti, Thomas C ^d   Kung, Fred Y L ^a   Law, Bonita K B ^a   Lau, Tai Shing ^b   Soon Lee, C ^e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^e NONE

Author keywords

Angiogenesis; Microvessel density; p53; Phyllodes tumor

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGE; AGED; ANGIOGENESIS; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; METASTASIS; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PHYLLODES TUMOR; STROMAL CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0142040166     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000089907.67419.42     Document Type: Article

References (42)

1. Azzopardi JG. Sarcoma of the breast. In: Bennington J, editor. Problems in breast pathology. Vol II. Major problems in pathology. Philadelphia: Saunders; 1979. p. 355-9.
2. Palmer ML, De Risi DC, Pelikan A, Patel J, Nemoto T, Rosner D, et al. Treatment options and recurrence potential for cystosarcoma phyllodes. Surg Gynecol Obstet 1990;170:193-6.
3. Kario K, Meada S, Mizuno Y, Makino Y, Tankawa H, Kitazawa S. Phyllodes tumor of the breast: a clinicopathologic study of 34 cases. J Surg Oncol 1990;45:46-51.
4. Rowell MD, Perry RR, Hsiu JG, Barranco SC. Phyllodes tumors. Am J Surg 1993;165:376-9.
5. Cole-Beuglet C, Soriano R, Kurtz AB, Meyer JE, Kopans DB, Goldberg BB. Ultrasound, X-ray mammography and histopathology of cystosarcoma phyllodes. Radiology 1983;146:481-6.
6. Rosen PP. Breast pathology. 2nd ed. Philadelphia: Lippincott-Raven; 2000. p. 176-97.
7. Weider NW, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
8. Horak E, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet 1992;340:1120-4.
9. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new, significant, and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
10. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
11. Vincent-Salomon A, Carton M, Zafrani B, Freneaux P, Nicolas A, Massemin B, et al. Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases. Cancer 2001;92:249-56.
12. Kato T, Kameoka S, Kimura T, Soga N, Abe Y, Nishikawa T, et al. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 2001;70:65-74.
13. de Jong JS, van Diest PJ, Baak JP. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000;36:306-12.
14. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst 1996;88:1764-9.
15. Karaiossifidi H, Kouri E, Arvaniti H, Sfikas S, Vasilaros S. Tumor angiogenesis in node-negative breast cancer: relationship with relapse free survival. Anticancer Res 1996;16:4001-2.
16. Santinelli A, Baccarini M, Colanzi P, Fabris G. Microvessel quantitation in intraductal and early invasive breast carcinomas. Anal Quant Cytol Histol 2000;22:277-84.
17. Medri L, Nanni O, Volpi A, Scarpi E, Dubini A, Riccobon A, et al. Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer 2000;89:74-80.
18. Axelsson K, Ljung BM, Moore DH 2nd, Thor AD, Chew KL, Edgerton SM, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:997-1008.
19. Van Hoef ME, Knox WF, Dhesi SS, Howell A, Schor AM. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 1993;29A:1141-5.
20. Morphopoulos G, Pearson M, Ryder WD, Howell A, Harris M. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol 1996;180:44-9.
21. Nakopoulou L, Lekkas N, Lazaris AC, Athanassiadou P, Giannopoulou I, Mavrommatis J, et al. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors. Anticancer Res 1999;19:4547-53.
22. Gonzalez-Palacios F, Sancho M, Martinez JC, Bellas C. Microvessel density, p53 overexpression, and apoptosis in invasive breast carcinoma. Mol Pathol 1997;50:304-9.
23. Zolota V, Gerokosta A, Melachrinou M, Kominea A, Alerta C, Scopa CD. Microvessel density, proliferating activity, p53 and bcl-2 expression in in situ ductal carcinoma of the breast. Anticancer Res 1999;19:3269-74.
24. Heffelfinger SC, Yassin R, Miller MA, Lower EE. Cyclin D1, retinoblastoma, p53, and Her2/neu protein expression in preinvasive breast pathologies: correlation with vascularity. Pathobiology 2000;68:129-36.
25. Tas F, Yavuz E, Aydiner A, Saip P, Disci R, Iplikci A, et al. Angiogenesis and p53 protein expression in breast cancer: prognostic roles and interrelationships. Am J Clin Oncol 2000;23:546-53.
26. Lee JS, Kim HS, Jung JJ, Kim YB, Park CS, Lee MC. Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior. Anal Quant Cytol Histol 2001;23:161-8.
27. Ozer E, Canda T, Kurtodlu B. The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas. Cancer Lett 1997;121:119-23.
28. Tse GM, Ma TK, Chan KF, Law BK, Chen MH, Li KH, et al. Increased microvessel density in malignant and borderline mammary phyllodes tumours. Histopathology 2001;38:567-70.
29. Tse GM, Putti T, Kung FY, Scolyer RA, Law BK, Lau TS, et al. Increased p53 protein expression in malignant mammary phyllodes tumors. Mod Pathol 2002;15:734-40.
30. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
31. Laforga JB, Aranda FI. Angiogenic index: a new method for assessing microvascularity in breast carcinoma with possible prognostic implications. Breast J 2000;6:103-7.
32. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995;177:275-83.
33. Hansen S, Grabau DA, Rose C, Bak M, Sorensen FB. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 1998;78:1563-73.
34. Ahlgren J, Risberg B, Villman K, Bergh J. Angiogenesis in invasive breast carcinoma-a prospective study of tumour heterogeneity. Eur J Cancer 2002;38:64-9.
35. Wapnir IL, Barnard N, Wartenberg D, Greco RS. The inverse relationship between microvessel counts and tumor volume in breast cancer. Breast J 2001;7:184-8.
36. Leek RD. The prognostic role of angiogenesis in breast cancer. Anticancer Res 2001;21:4325-31.
37. Arapandoni-Dadioti P, Giatromanolaki A, Trihia H, Harris AL, Koukourakis MI. Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis. Cancer Lett 1999;137:145-50.
38. Guidi AJ, Berry DA, Broadwater G, Perloff M, Norton L, Barcos MP, et al. Association of angiogenesis in lymph node metastases with outcome of breast cancer. J Natl Cancer Inst 2000;92:486-92.
39. Paradiso A, Ranieri G, Silvestris N, Naccarato G, Bevilacqua G, Mangia A, et al. Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasis. Clin Exp Med 2001;1:127-32.
40. Huang SP, Wu MS, Shun CT, Wang HP, Lin JT. Tumor angiogenesis increases with nuclear p53 accumulation in gastric carcinoma. Hepatogastroenterology 2002;49:1453-6.
41. Kern A, Taubert H, Scheele J, Rudroff C, Mothes H, Kappler M, et al. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers awnd corresponding liver metastases. Int J Oncol 2002;21:243-9.
42. Goodheart MJ, Vasef MA, Sood AK, Davis CS, Buller RE. Ovarian cancer p53 mutation is associated with tumor microvessel density. Gynecol Oncol 2002;86:85-90.